DPHARMA

Quarterly rpt on consolidated results for the financial period ended 30 Jun 2022

DUOPHARMA BIOTECH BERHAD

Financial Year End 31 Dec 2022
Quarter 2 Qtr
Quarterly report for the financial period ended 30 Jun 2022
The figures have not been audited
  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2022

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Jun 2022
30 Jun 2021
30 Jun 2022
30 Jun 2021
$$'000
$$'000
$$'000
$$'000
1 Revenue
181,742
155,439
367,683
321,893
2 Profit/(loss) before tax
21,473
20,197
48,119
43,373
3 Profit/(loss) for the period
16,311
15,390
36,602
33,004
4 Profit/(loss) attributable to ordinary equity holders of the parent
16,311
15,390
36,602
33,004
5 Basic earnings/(loss) per share (Subunit)
1.72
1.63
3.88
3.51
6 Proposed/Declared dividend per share (Subunit)
0.50
0.50
0.50
0.50


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.6700
0.6600

Remarks :
Pursuant to MFRS 133, Earnings Per Share for the corresponding quarter and year to date ended 30 June 2021 had been retrospectively adjusted to reflect the effect of the bonus shares allotted on 7 September 2021.

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 16 Aug 2022
Category Financial Results
Reference Number FRA-29072022-00006